Pasithea Therapeutics (KTTA) Asset Utilization Ratio (2022 - 2024)
Historic Asset Utilization Ratio for Pasithea Therapeutics (KTTA) over the last 3 years, with Q1 2024 value amounting to 0.01.
- Pasithea Therapeutics' Asset Utilization Ratio rose 5128.55% to 0.01 in Q1 2024 from the same period last year, while for Mar 2024 it was 0.01, marking a year-over-year increase of 5128.55%. This contributed to the annual value of 0.01 for FY2022, which is N/A changed from last year.
- Pasithea Therapeutics' Asset Utilization Ratio amounted to 0.01 in Q1 2024, which was up 5128.55% from 0.01 recorded in Q4 2023.
- Pasithea Therapeutics' 5-year Asset Utilization Ratio high stood at 0.02 for Q2 2023, and its period low was 0.0 during Q1 2022.
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.01 (2023), whereas its average is 0.01.
- Examining YoY changes over the last 5 years, Pasithea Therapeutics' Asset Utilization Ratio showed a top increase of 352148.8% in 2023 and a maximum decrease of 112.08% in 2023.
- Over the past 3 years, Pasithea Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2022, then dropped by 1.12% to 0.01 in 2023, then soared by 41.22% to 0.01 in 2024.
- Its Asset Utilization Ratio was 0.01 in Q1 2024, compared to 0.01 in Q4 2023 and 0.02 in Q3 2023.